Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
Ravishankar D, Albadawi DAI, Chaggar V, Patra PH, Williams HF, Salamah M, Vaiyapuri R, Dash PR, Patel K, Watson KA, Vaiyapuri S.
Ravishankar D, et al. Among authors: dash pr.
Eur J Pharmacol. 2019 Nov 5;862:172627. doi: 10.1016/j.ejphar.2019.172627. Epub 2019 Aug 25.
Eur J Pharmacol. 2019.
PMID: 31461638